Xenetic Biosciences, Inc. earnings per share and revenue
On 10 de nov. de 2025, XBIO reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.49 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 642.60 mil, with a --% difference.
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.53 USD, with revenue projected to reach 703.80 mil USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
What were Xenetic Biosciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Xenetic Biosciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Xenetic Biosciences, Inc.'s Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Xenetic Biosciences, Inc. expected to report next?
The next earning report is scheduled for 16 de mar. de 2026.
What are the forecasts for Xenetic Biosciences, Inc.'s next earnings report?
Based on 3
analistas, Xenetic Biosciences, Inc. is expected to report EPS of -$0.53 and revenue of $703.80K for Q4 2025.